Object. The purpose of this study was to assess the incidence and risk factors of postoperative nausea and vomiting (PONV) after craniotomy because most available data about PONV in neurosurgical patients are retrospective in nature or derive from small prospective studies.
D espite great advances in modern anesthesia, PONV remains a perioperative challenge and continues to occur in 20% to 30% of the general surgical population. 2, 3, 13, 27 Although a large number of patient-related factors have been evaluated, the actual influence of specific surgical procedures on the risk for PONV continues to be a highly debated topic. 1, 3 While there are some indications that intracranial procedures appear to predispose a patient to a higher incidence of PONV, it has not been specifically investigated until now. 4, 6, 11, 18 Vomiting and retching could result in swelling or hemorrhage at the surgical site. Thus, PONV might endanger outcomes after intracranial procedures and knowledge of the underlying factors will improve patient management. However, most available data are retrospective in nature or derive from small prospective studies evaluating antiemetic drugs. [7] [8] [9] [10] 12, 14, 17, [19] [20] [21] 23, 24, 26, 28 The hypothesis of this prospective investigation was that patient-and anesthetic-related risk factors as well as intracranial surgery itself influence PONV. Therefore the present study has prospectively assessed the overall incidence of PONV after craniotomy in a large patient population.
Methods

Study Criteria
After approval by the local ethics committee, a prospective study was initiated that included 256 adult patients requiring elective supratentorial or infratentorial craniotomy within 1 year. This prospective observational study design contained no intervention, and surgical treatment and anesthetic management were left to the decision of the attending teams. As a consequence, written informed consent of the patients was not requested.
The study exclusion criteria were: patients under 18 years of age, pregnancy, emergency surgery, American Society of Anesthesiology physical status Class 5, regular communication not possible, acoustic neurinoma, trans-sphenoidal surgery, and procedures requiring only a bur hole. 22 Patients requiring prolonged mechanical ventilation (> 2 hours after end of surgery) were also excluded.
Anesthesia Procedures
General anesthesia was induced with 0.2-0.3 mg/kg sufentanil intravenously, followed by 2-3 mg/kg propofol intravenously or 0.2-0.3 mg/kg etomidate. Intravenous atracurium (0.5 mg/kg) or succinylcholine (1-1.5 mg/kg) was used to facilitate tracheal intubation. Anesthesia was maintained with 1.5%-2.0% sevoflurane (end-tidal concentration) or with propofol (5-8 mg/kg/hr) as total intravenous anesthesia. Total intravenous anesthesia was used in patients with a medical history of PONV or motion sickness. Similarly, granisetron (1 mg) and/or dexamethasone (4-8 mg) were administered for the prevention of PONV if deemed appropriate by the attending anesthesiologist. For prevention of cerebral edemata, 40-80 mg of dexamethasone was administered intraoperatively or postoperatively, if necessary. Analgesic management consisted of intermittent boluses of sufentanil or an infusion of remifentanil (0.05-0.5 mg/kg/min). At the end of surgery, anesthesia was discontinued and the patient's trachea was extubated upon full clinical recovery. Reversal of residual neuromuscular blockade was not necessary in any of the patients. Postoperatively, patients were transferred to the neurosurgical intensive care unit.
Outcome Measures
Episodes of nausea and vomiting during the first 24 hours after the operation, and antiemetic and analgesic treatment were documented in a specific chart. Nausea was defined as an unpleasant sensation associated with the urge to vomit. The severity or duration of nausea was not recorded. Vomiting was defined as an expulsion of stomach contents. Retching was treated like vomiting in view of its pathophysiological similarity. No PONV was defined as no episodes of vomiting or retching and no report of nausea throughout the time frame under study. Postoperatively, antiemetics and analgesics were used if considered appropriate by the medical staff of the intensive care unit. Rescue medication for PONV included 5-HT 3 receptor antagonists (granisetron, tropisetron), dopamine antagonists (metoclopramide), antihistamines (dimenhydrinate), and steroids (dexamethasone). Postoperative pain was treated with nonopioids (paracetamol, ibuprofen, metamizole, or diclofenac) and piritramide, an opioid with pure m-ligand properties.
Postoperative nausea and vomiting occurs at widely disparate rates depending on the patient population in question and possibly the surgical procedure undertaken. Whereas a large number of patient-related factors have been evaluated, the actual influence of the specific surgical procedure on the risk of PONV is difficult to evaluate. 1, 3 This evaluation would only be possible if a similar group of patients were investigated with the same form of anesthesia and comparable risk factors-one group having an operation and one group without operation. However, such an investigation would be unethical. To overcome this problem, only an indirect approach can be used to evaluate the influence of the operation on PONV using a model that predicts the patients' risk for PONV (including typical patient-related risk factors and typical anesthesiarelated risk factors). This calculated risk for PONV can then be compared with the actual incidence of PONV in the investigated group of patients. If the measured PONV incidence is higher than the predicted PONV incidence it is possible that the operation per se carries a higher PONV risk. However, the forecast model, specifically the POV score by Apfel that is used in the present study, is only evaluated for patients receiving a balanced anesthesia regimen and not total intravenous anesthesia, and for patients who do not receive any antiemetics during the operation, because antiemetics and total intravenous anesthesia would influence the incidence of PONV. The comparator group, therefore, includes only patients who received balanced anesthesia and to whom no prophylactic antiemetics have been given during the operation. The POV score is surgery-independent and uses the most important anesthesia-and patient-related risk factors.
1 Neurosurgical procedures are inherently very lengthy procedures, but the effect of duration of anesthesia is also taken into account by this risk score.
Statistical Analysis
Binominal tests were performed using SPSS (versions 12.0, SPSS Inc.) to compare the proportion of patients having POV and the proportion predicted to have POV according to their calculated risk. A logistic regression analysis was performed using SPSS to identify covariates associated either with nausea or vomiting. Data examined included individual factors (sex, medical history of PONV or motion sickness, smoking status, age, and BMI), anesthesia-related factors (balanced anesthesia vs total intravenous anesthesia, duration of anesthesia, and intraoperative application of piritramide, antiemetics, or steroids) and surgical side (supratentorial vs infratentorial). No adjustment of probability values due to multiple testing was performed. Therefore, only exploratory analysis was possible and probability values are descriptive. The intention of the article is to detect possible risk factors of PONV after craniotomy.
Results
A total of 256 patients were enrolled in the study with a mean age of 54 ± 16 years and a mean duration of anesthesia of 281 ± 98 minutes. Thirteen patients who could not be extubated within 2 hours after surgery were excluded from further analysis. Nine patients were excluded due to change in the anesthetic management from sevoflurane to propofol. Five patients were excluded for incomplete documentation. Thus, the data from 229 patients were included in the analysis.
The overall incidence of PONV during the first 24 hours after craniotomy was 47% (107 patients). Postoperative nausea was recorded in 98 patients (43%) and emesis in 76 patients (33%). Antiemetics were administered intraoperatively to 25 patients (11%) and postoperatively to 99 patients (43%; Table 1 ). None of the patients who vomited suffered from rebleeding or severe aspiration after the operation.
Multivariate logistic regression identified female sex as a risk factor for postoperative nausea (OR 4.25, 95% CI 2.3-7.8) and vomiting (OR 2.62, 95% CI 1.4-4.9). The frequency of PONV was lower in patients receiving steroids intraoperatively. Logistic regression analysis identified absence of intraoperative steroids as a risk factor for both nausea (OR 3.76, 95% CI 2.06-6.88) and vomiting (OR 4.48, 95% CI 2.4-8.37). In the subgroup of 94 patients undergoing balanced anesthesia and not receiving any antiemetic medication the calculated incidence of POV (31%) was lower compared with the actual incidence of POV (49%; p = 0.0004). Smoking status, patient age, and BMI were not associated with PONV (Table 2) . Intraoperative antiemetic prophylaxis did not affect the incidence of PONV. Postoperative nausea and vomiting were independent of the anesthetic technique used (inhalational anesthesia vs total intravenous anesthesia), duration of anesthesia, the application of intraoperative piritramide, and occurrence after infratentorial as well as after supratentorial procedures.
Discussion
The purpose of the present study was to evaluate the overall incidence and potential risk factors of PONV in patients undergoing supratentorial or infratentorial craniotomy. This prospective investigation involved 229 patients who all underwent intracranial procedures, and PONV was systematically assessed within 24 hours after surgery. Postoperative nausea and vomiting occurred in 47% of the patients after craniotomy. These results correspond to the widespread belief that intracranial procedures are associated with a high incidence of PONV. In a retrospective analysis of 199 neurosurgical patients, the incidence of PONV after craniotomy was as high as 54%.
9
Other studies reported incidence rates of postcraniotomy PONV ranging from 10% to 74% (Table 3) . However, these studies are either retrospective in nature, observe a short postoperative period, or were performed to test the effects of antiemetic drugs. In contrast, the present study prospectively assessed the incidence of PONV in the largest collection of patients undergoing purely elective craniotomy.
The high incidence of PONV after craniotomy when compared with the regular PONV rate of 20%-30% in the general surgical population suggests that intracranial procedures per se carry a high risk for PONV.
1-3 Certain procedures (gynecological and strabismus surgery) are typically associated with a high rate of PONV. 5, 15 However, this does not allow for the conclusion that the type of surgery itself is the crucial risk factor for PONV, because it might also reflect a certain patient population (such as female sex in gynecology) or a particular anesthetic factor. The strongest predictors of PONV that have been identified so far are patient-and anesthetic-related factors (female sex, history of PONV, duration of surgery, use of postoperative opioids, and nonsmoking status). Based on these predictors, simplified risk scores have been developed to identify patients at risk for PONV. 1, 3 Considering that nausea is a subjective phenomenon and cannot clearly be distinguished from dizziness after intracranial surgery, the Apfel POV score has the advantage of referring only to vomiting. This risk score is evaluated for patients undergoing inhalational anesthesia and not receiving antiemetic drugs. As a consequence, the predicted POV rate referred to the suitable subgroup of patients undergoing balanced anesthesia without any form of antiemetic prophylaxis. The procedural risk (the type of operation) is not included in those scores. Therefore a surgery-independent risk score such as the Apfel POV score can be compared with the observed incidence of postoperative vomiting in our population. Patients' predicted risk of POV in this subgroup was 31%, whereas the observed incidence of vomiting in this subgroup was 49%. One reason might be that intracranial surgeries pose an independent risk for vomiting. Possibly, the vomiting center (area postrema) is directly manipulated by the surgical procedure or it is activated by humoral factors released during surgery.
The chemoreceptor trigger zone is located in the infratentorial compartment and the proximity of these structures to the surgical field may increase the risk of vomiting, especially after posterior fossa surgery. This study did not find that the infratentorial side significantly influenced PONV. It cannot be ruled out that the power of the study was inadequate to identify the infratentorial approach as one risk factor for PONV. However, other prospective studies have also failed to find that the infratentorial side significantly influenced PONV. 12, 14, 25 In contrast, 2 retrospective studies found a positive correlation between infratentorial surgery and increased risk of PONV. 9, 17 Only 1 prospective study confirmed this observation, but the validity of that investigation was limited because approximately half of the supratentorial craniotomies were performed as awake craniotomies, which are associated with a decreased risk of PONV per se. 21 Therefore, there has not been any evidence yet that the incidence of PONV is affected by the side of craniotomy.
Intraoperative steroids, administered for prophylaxis of PONV (4-8 mg dexamethasone) or for treatment of brain edemata (40-80 mg dexamethasone) reduced the incidence of both nausea and vomiting. Although the antiemetic mechanisms of steroids are unclear, dexamethasone was included in PONV treatment guidelines as an antiemetic drug.
2,28
The occurrence of PONV after craniotomy was influenced by female sex. This is in accordance with prospective cohort studies that identified female sex as the most important individual risk factor for both nausea and vomiting. Adult women are approximately 3 times more likely to suffer from PONV than men. 3 The underlying pathophysiology for this phenomenon has yet to be elucidated, but female hormones appear to be a reasonable explanation. 5, 15 Postoperative nausea and vomiting was not influenced by BMI in the present study, which is consistent with other studies according to a systematic review.
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For several established predictors of PONV such as nonsmoking status, history of PONV, and intraoperative administration of opioids, no positive correlation could be identified. The risk of PONV is reduced in cigarette smokers by unknown mechanisms. Nevertheless, in the pres- ent study no differences were found in the incidence of PONV in smokers compared with nonsmokers. Although evidence is widespread that patients with a positive medical history of PONV are susceptible to PONV, a history of PONV or motion sickness were not predictors of PONV after craniotomy in the present study. Furthermore, logistic regression revealed that both total intravenous-based anesthesia and intraoperative administration of antiemetic drugs did not reduce the risk for PONV. It is likely that total intravenous anesthesia and PONV prophylaxis were applied to all patients with a history of PONV and motion sickness. As a consequence, the lack of efficacy of antiemetic prophylaxis may merely reflect a reduction of the increased baseline risk, suggesting an adequate treatment of patients with an increased risk of PONV. In the logistic regression analysis the dependent variables (presence and absence of nausea or vomiting) were dichotomous. Thus, total intravenous-based anesthesia and antiemetic drugs failed to show statistically significant differences. But the reduction that might be expected with a total intravenousbased anesthesia alone is approximately a 20% relative risk reduction. If one examines the data in Table 2 , the risk reduction associated with both nausea and vomiting with total intravenous-based anesthesia compared with a balanced anesthetic with sevoflurane is certainly within this 20% limit.
There was no association between the duration of anesthesia and the incidence of PONV. This lack of association may be due to the exclusion of patients with short operations requiring bur holes, resulting in a relatively homogeneous collection of patients with similar operative durations. Intraoperative administration of piritramide did not influence PONV. The amount of opioids is important for the development as well as the severity of PONV. However, the patients did not require high amounts of opioids, which might explain the lack of this unpleasant side effect of piritramide. The present study was not designed to investigate the influence of postoperative opioids on PONV. A chronologically precise distinction between bolus injection of opioids on the one hand and the occurrence of PONV on the other hand would have been necessary.
Conclusions
The main goal of this prospective survey was to determine the incidence of PONV and to identify patient-, anesthetic-and surgical-related risk factors in patients undergoing craniotomy. The overall incidence of PONV was 47%. As we expected, one important predictive factor associated with an increased risk of PONV was female sex. This study showed that the incidence of PONV was lower in patients receiving steroids intraoperatively. Furthermore, intracranial surgery itself appeared to be a risk factor for PONV. Although none of the patients who vomited suffered from rebleeding or aspiration, nausea and vomiting are nevertheless very unpleasant and stressful for neurosurgical patients who should be identified as being at high risk of developing PONV. Nevertheless, routine prophylactic use of antiemetics for PONV prevention is not cost effective, but a single-drug policy is suggested for mild-to moderate-risk patients. 11 Effective prevention of PONV in neurosurgical patients requires accurate risk stratification by means of a PONV scoring system. In the presence of at least 1 or 2 individual risk factors, propofol should be used for maintenance of anesthesia and corticoids at low doses should be considered as an antiemetic drug.
